HealthEquity, Inc. (NASDAQ:HQY) Holdings Lifted by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 1.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 581,529 shares of the company’s stock after acquiring an additional 8,594 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 0.67% of HealthEquity worth $50,128,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Rise Advisors LLC acquired a new stake in shares of HealthEquity during the 1st quarter valued at $28,000. Cape Investment Advisory Inc. acquired a new stake in shares of HealthEquity during the fourth quarter worth $27,000. International Assets Investment Management LLC purchased a new stake in shares of HealthEquity during the second quarter valued at $35,000. YHB Investment Advisors Inc. acquired a new position in shares of HealthEquity in the 1st quarter valued at $40,000. Finally, Fidelis Capital Partners LLC purchased a new position in HealthEquity in the 1st quarter worth about $42,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Performance

NASDAQ HQY opened at $79.53 on Friday. HealthEquity, Inc. has a twelve month low of $61.81 and a twelve month high of $88.26. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a market cap of $6.92 billion, a P/E ratio of 86.45, a PEG ratio of 1.19 and a beta of 0.52. The company’s 50-day simple moving average is $76.17 and its 200 day simple moving average is $79.32.

Analyst Ratings Changes

HQY has been the subject of a number of analyst reports. Wells Fargo & Company upped their price objective on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, June 20th. KeyCorp boosted their price target on shares of HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Wednesday, June 5th. Raymond James raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Friday, June 7th. Robert W. Baird lifted their price objective on shares of HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Finally, Barrington Research restated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a report on Friday. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus target price of $103.83.

Insider Activity

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the transaction, the director now directly owns 6,070 shares in the company, valued at $497,072.30. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 75,031 shares of company stock worth $6,103,625. Company insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.